Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic variability of sunitinib in metastatic kidney cancer
2014-005534-55Phase 4Completed
- Sponsor
- CHU Nîmes
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sunitinib in kidney cancer, sponsored by CHU Nîmes. Started Jul 2015; status: completed.
02
Drugs
sunitinib
03
Conditions
kidney cancer
Beyond the preview
Go deeper on 2014-005534-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005534-55.